MedTrace Logo

Two Different Regimens of Misoprostol in Retained Placenta

NCT02704780 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 509

Last updated 2019-02-22

No results posted yet for this study

Summary

This study evaluates intra umbilical vein injection of 800 µg versus 400 µg misoprostol for the treatment of retained placenta to reduce the need of manual removal of placenta under general anaesthesia

Conditions

  • Postpartum Haemorrhage
  • Retained Placenta

Interventions

DRUG

Misoprostol

2 regimes of misoprostol 400 microgram and 800 microgram injections used for 2 groups of women

Sponsors & Collaborators

  • Hawler Medical University

    lead OTHER

Principal Investigators

  • Shahla K. Alalaf, professor · Hawler Medical University

  • Namir G. Al Tawil, Professor · Hawler Medical University

  • Ariana Kh. Jawad, Assistant professor · KBMS

  • Bahar Q. Muhammad, CABOG · Maternity Teaching Hospital

  • Jinan N. Hassan, IBMS · Duhok university

  • Salim A. Salim, Master · Al-Azhar University

  • Khalida M. Ameen, CABOG · Karkuk Medical college

  • Maryam B. Mahmood, FICOG · Sulaimani Maternity Hospital

  • Khansa H. Abdul Rahman, MBChB · Maternity Teaching Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2019-02-01
Completion
2019-02-14

Countries

  • Iraq

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02704780 on ClinicalTrials.gov